Technology
Health
Medical

Pulse Biosciences

$17.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.21 (-1.15%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell PLSE and other stocks, options, ETFs, and crypto commission-free!

About

Pulse Biosciences, Inc Common Stock (DE), also called Pulse Biosciences, is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary Nano-Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. Read More The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.

Employees
54
Headquarters
Hayward, California
Founded
2014
Market Cap
374.79M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
88.12K
High Today
$18.50
Low Today
$17.88
Open Price
$18.20
Volume
10.76K
52 Week High
$22.50
52 Week Low
$8.60

Collections

Technology
Health
Medical
Energy
2016 IPO
US
North America

Earnings

-$0.64
-$0.57
-$0.50
-$0.43
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 7, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.